Recently, urologists have started using this therapy to treat erectile dysfunction (ED). University of Utah Health offers shockwave therapy as an option for Gainswave Treatment near Rock Hill SC. Shockwave therapy is a medical treatment that has existed for many years. It is often used as a non-invasive treatment option for kidney stones and orthopedic injuries. The University of Utah Health offers shockwave therapy as an option for patients suffering from erectile dysfunction.
Shockwave therapy is generally recommended for patients who don't respond well to medications or who don't want more invasive treatments. Shock waves (SW) are acoustic waves that carry energy and, when propagated through a medium, can be directed and focused in a non-invasive way to affect a selected and distant anatomical region. When LI-ESWT is applied to an organ, relatively weak but concentrated electromagnetic waves interact with selected deep tissues, where they cause mechanical stress and microtrauma. This stress and microtrauma (also known as shear stress) induce a cascade of biological reactions that result in the release of angiogenic factors that, in turn, trigger the neovascularization of the tissue with the consequent improvement of the blood supply.
Since one of the underlying functional causes of erectile dysfunction is poor cavernous arterial blood flow, we hypothesized that inducing neovascularization using LI-ESWT could improve cavernous arterial flow, which in turn would improve erectile function. If this hypothesis could be tested, LI-ESWT could become an effective, non-invasive treatment for erectile dysfunction. One month after LI-ESWT, erectile function improved in 15 men. An increase of more than five points in the domain score of the International Index of Erectile Function: Erectile Function (IIEF-EF) was observed in 14 men and of more than 10 points in 7 men.
Five men did not respond to the LI-ESWT. Overall, the average increase in IIEF-EF domain scores was 7.4 points (13.5 to 20.9, p = 0.00). In addition, erectile function and penile blood flow were measured using nocturnal penile tumescence (TNP) and penile venous occlusion plethysmography, respectively. The LI-ESWT improved all parameters of the NPT, especially in the 15 men who responded to the LI-ESWT, where there were significant increases in the duration of erections and in penile stiffness. Penile blood flow also improved significantly and a strong correlation was found between increased IIEF-EF scores and improved blood flow in the penis after the one-month follow-up exam.
At the 6-month follow-up visit, 10 men reported that they continued to have spontaneous erections sufficient for penetration and that they did not need PDE5i support. In both studies, a strong and significant correlation was found between the subjective evaluation of sexual function using validated questionnaires on sexual function and the objective results of penile blood flow and erectile function. In addition, none of the men in both studies reported pain associated with treatment or any adverse effects during or after treatment. LI-ESWT is a revolutionary treatment for erectile dysfunction and probably possesses unprecedented qualities that can rehabilitate erectile tissue.
The clinical improvement of subjective erectile function, together with the significant improvement of penile hemodynamics after LI-ESWT, confirm that LI-ESWT has unique properties that can create a new standard of treatment for men with erectile dysfunction. The LI-ESWT is both feasible and tolerable and has no adverse or unwanted effects. Its main advantage is its ability to improve and potentially restore erectile function in men with erectile dysfunction without the need for additional pharmacotherapy. Therefore, the LI-ESWT is an attractive addition to the arsenal of existing treatment options for erectile dysfunction.
In the near future, we expect LI-ESWT to be used for the long-term clinical treatment of erectile dysfunction, either as an alternative or as a potentiator to current treatments for erectile dysfunction. Ilan Gruenwald, Neurourology Unit at Rambam Medical Center and Rappaport Medical School, Technion, Haifa 34679, Israel. Boaz Appel, Neurourology Unit, Rambam Medical Center and Rappaport Medical School, Technion, Haifa, Israel. Kitrey, Neurourology Unit, Rambam Medical Center and Rappaport Medical School, Technion, Haifa, Israel Yoram Vardi, Neurourology Unit, Rambam Medical Center and Rappaport Medical School, Technion, Haifa, Israel.
Early results show that the procedure can help resolve mild to moderate erectile dysfunction. Petar Bajic once again joins the Butts and Guts podcast, this time to talk about treating erectile dysfunction (ED) with low-intensity shockwave therapy. Listen to learn more about how this type of therapy is used to treat erectile dysfunction. Erectile dysfunction (ED) is more common than many men think and is often related to a combination of physical, emotional, and lifestyle factors.
Learn about the signs to look out for, what to expect at your first visit, and non-surgical treatment options that can help you regain confidence and sexual health. Its objective is to compare the efficacy of Li-ESWT with that of a placebo in the treatment of erectile dysfunction of vascular origin, with the objective of evaluating erectile function and penile hardness during erection using the IIEF-EF and the EHS, respectively. Erectile dysfunction: prospective, randomized, placebo-controlled study evaluating the effect of low-intensity extracorporeal shockwave therapy (LI-ESWT) in men with erectile dysfunction after radical prostatectomy. But if you were the first case I mentioned where you get a very strong response to the pill but don't like the side effects, you could get by without having to use the pill if you were to undergo shock wave treatment.
The participants received shock wave therapy or a sham treatment once or twice a week for three to six weeks. On the other hand, factors such as age, diabetes, hypertension, coronary heart disease or hyperlipidemia are elements that influence the severity of erectile dysfunction and, therefore, the therapeutic effect of shock waves; however, relevant conclusions have not yet been obtained about factors related to erectile dysfunction and how they influence the response to treatment. Most people can return to normal activities the day after shockwave therapy, but the urologist will consider whether you need to restrict your activity for longer to recover. It is not approved by the FDA for the treatment of erectile dysfunction, but in several recent studies conducted around the world, it has shown promise for treating men who have erectile dysfunction due to reduced blood flow, which is the most common cause of erectile dysfunction.
While the daily administration of a PDE5i instead of an on-demand treatment addresses some of these problems, it does not change the physiopathology of the erectile process. Currently, only a small number of men with erectile dysfunction can be offered treatment that restores their spontaneous erectile function. Overall, clinical studies have shown that shockwave therapy is effective and safe, but more research is needed to identify potential risks and the best treatment protocols for a person with erectile dysfunction. Recently, data has accumulated from several studies that indicate that this objective could probably be achieved with extracorporeal low-intensity shock wave therapy (LI-ESWT) of the corpora cavernosa.
Erectile function was measured with IIEF and EHS one, three and six months after treatment.